Sulagna Sanyal

Title: The Innovative Contributions of Sulagna Sanyal

Introduction

Sulagna Sanyal is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of three patents to her name, Sanyal's work is paving the way for new therapeutic options.

Latest Patents

Sanyal's latest patents include innovative compounds that serve as IL4I1 inhibitors. These compounds, described as Formula I or its pharmaceutically acceptable salts, are designed to prevent, treat, or act as remedial agents for IL4I1-related diseases. Another notable patent involves substituted tetrahydroquinolin compounds that act as indoleamine 2,3-dioxygenase (IDO) inhibitors. This patent discloses a compound of formula (I) and its potential uses in treating or preventing IDO-associated diseases or disorders.

Career Highlights

Throughout her career, Sulagna Sanyal has worked with leading companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and MSD International GmbH. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Sanyal has collaborated with notable professionals in her field, including Craig R. Gibeau and David L. Sloman. These collaborations have further enhanced her research and development efforts.

Conclusion

Sulagna Sanyal's innovative work in the pharmaceutical sector demonstrates her commitment to advancing medical science. Her patents reflect her dedication to finding solutions for complex health issues.